Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PDRN with ESWT and Exercise for Lateral Epicondylitis
NCT06753630Completed
- Sponsor
- Hallym University Chuncheon Sacred Heart Hospital
- Start
- Nov 2014
- Primary completion
- Nov 2015
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial of polideoxirybonucleotide in Lateral Epicondylitis (LET) (2 arms), sponsored by Hallym University Chuncheon Sacred Heart Hospital. Primary endpoint: Pain Reduction (Visual Analog Scale) at 12 weeks. Started Nov 2014; status: completed.
02
Drugs
polideoxirybonucleotide
03
Conditions
Lateral Epicondylitis (LET)
Beyond the preview
Go deeper on NCT06753630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06753630.